System Maintenance Notice

Please note that maintenance work is scheduled between 4 AM and 5 AM - CET. During this time, you may experience reduced performance. Thanks for your patience.

Abel Cordoba is an expert in Radiotherapy at Centre Oscar Lambret (France). Abel Cordoba has authored 78 publications, the most recent in 2026, and is an investigator in 8 clinical trials, 3 of them ongoing. SLR score: 360 (community average: 125). How the SLR is computed.

LeadR Profile

Abel Cordoba Centre Oscar Lambret France
360 ScienceLeadR Reputation 360

Unlock

Register Login
Network Map

Radiotherapy

Subspecialties: Oncology - Gynecology - Nuclear Medicine

Full career – Last 3 years

Main Topics

Publications and Clinical Studies

Publications – Clinical Studies

Profile data updated on

Organizations

Career arc: 2013 - 2026
Source: PubMed

Centre Oscar Lambret

Publications Synthesis

Sources: PubMed, OpenAlex

Number : 78

Citations

Citations: 442 1st author: 17 Last author: 8 Unique author: 0

Main journals

Cancer Radiother 15
Int J Gynecol Cancer 9
Radiother Oncol 8
Cervical cancer 5
Int J Radiat Oncol Biol Phys 5

Best Journals

Ann Oncol 1

Breakdown by type

Click a legend label to hide or show it in the chart.

Latest Publications

5 most recent indexed articles

Source: Pubmed

Title Journal Year Citations
Corrigendum to 'Radiotherapy and brachytherapy for cervical cancer : Recommendations of the Société française de radiothérapie oncologique' [Cancer Radiother 29 (2025) 104753].
PMID 42013680 — radiotherapy, uterine cervical neoplasms, brachytherapy, neoplasms		Cancer Radiother20260
In Reply to May et al.
PMID 41644213 — radiobiology		Int J Radiat Oncol Biol Phys20260
Radiotherapy and brachytherapy for cervical cancer: Recommendations of the Société française de radiothérapie oncologique.
PMID 41086563 — radiotherapy, uterine cervical neoplasms, brachytherapy, neoplasms, therapeutics		Cancer Radiother20250
Radiotherapy for endometrial cancer: 2025 update.
PMID 41086562 — radiotherapy, brachytherapy, neoplasms, endometrial neoplasms		Cancer Radiother20250
Role of radiotherapy in the treatment of primary vaginal cancer: Recommendations of the Société française de radiothérapie oncologique, 2025 update.
PMID 40961758 — radiotherapy, brachytherapy, neoplasms, vaginal neoplasms, therapeutics		Cancer Radiother20250

Clinical Studies 8

Sources: ClinicalTrials, EU CTIS

Synthesis

Principal Investigator: 2

By phase:

Phase 2 6
N/A 2

By status:

Recruiting 4
Completed 2
Active not recruiting 1
Terminated 1

By type:

Interventional 8

By Monocentric/Multicentric:

monocentric 3
multicentric2to4 0
multicentric5to9 0
multicentricup10 5

Main Topics

Ongoing Clinical Trials

3 ongoing trials started since 2021, where this expert is an investigator

Source: ClinicalTrials

Study Phase Status Start
A MULTICENTER SEEKING SIGNAL RANDOMISED OPEN LABEL PHASE II OF RELATLIMAB AND NIVOLUMAB VS NIVOLUMAB ALONE IN LOCALLY ADVANCED CERVICAL CANCERS
2024-514032-25-00 — uterine cervical neoplasms, neoplasms, nivolumab		Phase 2Active not recruiting2024
Assessment of the Long term Efficacy of Moderately Hypofractionated Neoadjuvant Radiotherapy Soft Tissue Sarcoma in the Limbs or Trunk Wall
NCT07507773 — radiotherapy, intensity-modulated, radiotherapy, gastrointestinal stromal tumors, sarcoma, research, tissues		Phase 2Recruiting2026
A Study to Evaluate Pre operative HYPOfractionated Radiation Therapy in Aged ( 70 Years Old) or Fragile ( 65 Years) Patients With Limb or Trunk Soft Tissue SARComa
NCT06022159 — radiotherapy, intensity-modulated, radiotherapy, conservative treatment, surgical procedures, operative, amputation, surgical, sarcoma, aged, therapeutics, tissues		Phase 2Recruiting2023

LeadR Networks

Main global connection map

Sources: PubMed, OpenAlex, ClinicalTrials, EU CTIS